In prostate cancer, a significant proportion of the tumoral mass consists of TAMs with an M2 phenotype, which release cytokines that suppress cytotoxic T-cells, recruit Tregs and express PD-L1, which results in a decreased effect of PD-L1 blockade [148]. The gene discussed is CD274; the disease is prostate carcinoma.